Home › NCT06569316

Genetic Testing for the Prevention of Cancer in American Indian Communities (JUNIPER Trial)

Journey to Understanding - American Indian Peoples Engagement in Cancer Research Arizona (JUNIPER)

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Male or female adults \>= 18 years of age
* Cancer patient undergoing active treatment or a cancer survivor
* Self-identify as American Indian

Exclusion Criteria:

* Unable to provide informed consent
* Individuals who are under 18 years of age
* Prisoners

About the study

This clinical trial is studying the genetic changes in cells associated with different types of cancer in American Indian (AI) populations in the Southwest to improve cancer screening, precision prevention, and therapeutic intervention for individual in these communities. AI tribes have much lower rates of cancer screening, have more limited access to healthcare, are more often diagnosed at later stages of disease, and have the poorest outcomes in all types of cancer when compared to any other racial and ethnic group in the United States. Due to these significant cancer health disparities, AIs have been understudied and little is known about the molecular characterization of tumors arising in AIs. Undergoing genetic testing of tumors may improve cancer outcomes in AI participants and communities.

What is being tested

• Biospecimen Collection (procedure)
• Communication Intervention (other)
• Genetic Testing (other)
• Survey Administration (other)

Sponsor: Mayo Clinic · Participants: 300 · Started: Sep 27, 2024

Contact the study team

• Clinical Trials Referral Office · Phone: 855-776-0015

Official record on ClinicalTrials.gov — NCT06569316

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.